Heartsciences signs first myovista insights™ platform customer, marking major commercial milestone

Southlake, tx, may 29, 2025 (globe newswire) -- heartsciences inc. (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (“ai”)-powered medical technology company focused on transforming ecgs/ekgs to enable earlier detection of heart disease, today announced the signing of its first commercial customer for the myovista insights™ platform: westcliffe health innovations, based in the united kingdom.
HSCS Ratings Summary
HSCS Quant Ranking